{
    "2015-02-13": [
        "Traders Purchase High Volume of Put Options on Celgene $CELG",
        "Attorney in space \"ZERO chance Bass IPR ever affects $CELG revlimid sales.\"",
        "For instance, no analyst lowered 12-mo price targets for $CELG -- all remain $144 to $150. Earnings/outlook support it."
    ]
}